KEMSA Ta Fara Binciken Halaye na Ƙasa don Haɓaka Daidaituwa da Ƙarfafa Ayyukan Kiwon Lafiyar Jama'a
Kwanan nan, Cibiyar Fasaha ta Shenzhen ta Kwalejin Kimiyya ta kasar Sin ta fitar da wani gagarumin sakamako na bincike a fannin fasahar kere-kere. Tsarin nanorobot na maganadisu da suka ɓullo da shi a karon farko ya sami cikakken tsarin maganin "ƙetare shingen kwakwalwar jini - madaidaicin kewayawa - fashewar fashewa", yana kawo maganin juyin juya hali ga cututtukan kwakwalwa kamar cutar Alzheimer.
Washington, Yuni 12, 2024 - Hukumar Abinci da Magunguna ta Amurka (FDA) a yau ta hanzarta amincewa da tsarin jiyya na "SOD1-ASO" (sunan mai suna Toferson) wanda Giant Pharmaceutical Swiss Novartis ya kirkira don maganin ciwon ƙwayar cuta na amyotrophic (ALS) wanda ya haifar da maye gurbi a cikin superoxide.1 (SOD dismutase1) Wannan shine farkon maganin jiyya a duniya wanda ke niyya da takamaiman nau'in ALS.
Binciken baya-bayan nan ya nuna cewa rashin barci na dogon lokaci ba wai kawai yana haifar da gajiya da raguwar ƙwaƙwalwar ajiya ba, har ma yana iya ƙara haɗarin cutar Alzheimer. Masana kimiyya sun gano cewa a lokacin barci, kwakwalwa ta fara "tsaftacewa yanayin" don cire sunadarai masu cutarwa, kuma yin latti yana rushe wannan tsari, yana hanzarta raguwar fahimi.
Rahoton na baya-bayan nan daga hukumar ta WHO ya yi gargadin cewa rikicin juriyar kwayoyin cutar yana kara ta'azzara. Idan ba a magance shi cikin gaggawa ba, zai iya haifar da mutuwar dubun-dubatar mutane a duniya cikin shekaru goma masu zuwa, abin da ke barazana ga tushen tsarin likitancin zamani.
EU ta amince da nasarar maganin donanemab na Alzheimer, wanda aka nuna yana rage raguwar fahimi da kashi 35%, amma farashinsa na shekara-shekara na dala 30,000 yana haifar da damuwa ga marasa lafiya a duk duniya.